India Misses 2025 Tuberculosis Elimination Target

INDIA MISSES ITS 2025 TARGET FOR TUBERCULOSIS ELIMINATION

WHY IN THE NEWS ?

  • WHO Report: The WHO’s Global Tuberculosis Report 2026, released on November 12, highlights that India has missed its national target of eliminating Tuberculosis (TB) by 2025, despite improvements in diagnosis and treatment.
  • Global Burden: India continues to account for nearly one-fourth of global TB cases, underlining the need for stronger public health interventions.

INDIA MISSES ITS 2025 TARGET FOR TUBERCULOSIS ELIMINATION

INDIA’S TB ELIMINATION TARGET AND PROGRESS:

  • National Target: India aimed to eliminate TB by 2025, five years ahead of the global Sustainable Development Goal (SDG) deadline of 2030, under the National Strategic Plan (NSP) 2017–2025.
  • Incidence Reduction: The NSP targeted an 80% reduction in incidence, from 217 cases per lakh population (2015) to 43 by 2025.
  • Mortality Reduction: It aimed to reduce TB deaths by 90%, from 32 to three deaths per lakh population, and prevent catastrophic costs for affected families.
  • Actual Progress: TB mortality declined by 38%, from 28 deaths per lakh in 2015 to 18 in 2025. However, this remains far above the national target.
  • Incidence Gap: WHO estimates show incidence declining from 237 per lakh in 2015 to 187 in 2024, a reduction of around 21%, substantially below the national target.
  • Diagnostic Expansion: Rapid molecular testing covered 46% of diagnosed cases in 2025, compared with 38% in 2024. However, delayed diagnosis, uneven healthcare access, private-sector underreporting and drug-resistant TB remain challenges.

REASONS FOR SHORTFALL AND UPDATED ESTIMATES

  • Social Factors: Undernutrition, overcrowding, poor ventilation and poverty increase TB vulnerability and transmission.
  • Economic Burden: Travel, investigations, nutrition and lost wages create financial difficulties, affecting treatment continuity.
  • Drug Resistance: Multidrug-resistant TB requires complex treatment. Shorter all-oral BPaLM regimens have reduced treatment duration for eligible patients.
  • Missing Estimates: WHO has withheld India’s 2025 incidence estimate pending assessment of district-level sentinel surveillance data from 50 representative districts. Updated estimates are expected in early 2027.
  • Data Distinction: Incidence means new cases occurring over a period; prevalence means existing cases; notifications represent diagnosed and reported cases. These figures are not interchangeable.

ABOUT TUBERCULOSIS AND INDIA’S HEALTH INITIATIVES:

●      Causative Agent: TB is an infectious disease caused by Mycobacterium tuberculosis, primarily affecting the lungs.

●      Transmission: It spreads through airborne particles released by infected individuals.

●      End TB Strategy: WHO aims to reduce global TB deaths by 75% and incidence by 50% by 2025, compared with 2015.

●      NTEP: The National Tuberculosis Elimination Programme implements India’s TB-control strategy through diagnosis, treatment and prevention.

●      Ni-kshay: A digital platform supporting patient notification, monitoring and treatment management.

●      SDG 3.3: Calls for ending the TB epidemic by 2030.